BioSpace News Archive

AXIM Biotechnologies, Inc. announced that it has started selling its ophthalmic point-of-care diagnostic product portfolio in advance of the American Academy of Ophthalmology Annual Meeting through its exclusive commercialization partner Verséa Ophthalmics, LLC, a subsidiary of Verséa Holdings, Inc., one of the fastest growing healthcare companies in the U.S.

Corium, Inc. announced that ADLARITY is now available for prescription in the U.S. for the treatment of patients with mild, moderate, or severe dementia of the Alzheimer’s type.

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced results from a focused analysis of treatment with verdiperstat in the HEALEY ALS Platform Trial in amyotrophic lateral sclerosis (ALS).

ImmunoGen, Inc. today announced several data presentations for mirvetuximab soravtansine (mirvetuximab) at the 2022 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in New York City.

Viewpoint Molecular Targeting, Inc. today announced that it has entered into a definitive agreement to merge with Isoray, Inc (NYSE AMERICAN:ISR), a medical technology company and innovator in seed brachytherapy.

MP Biomedicals, LLC has recently expanded its portfolio of COVID-19 related research products to include a wide selection of highly pure SARS-CoV-2 recombinant proteins.

SELLAS Life Sciences Group, Inc. announced today data from a bioequivalence study for GFH009, its potent, highly selective, clinical-stage small molecule that inhibits cyclin-dependent kinase 9 (CDK9).

Biomerica, Inc. announced that the Company’s Aware® Breast Self Exam device and EZ Detect Colon Disease test are now being sold on Amazon and fulfilled by Amazon.

Palisade Bio, Inc. today announced its abstract was accepted for presentation at the American College of Surgeons (ACS) Clinical Congress 2022 being held October 16-20, 2022, in San Diego, CA.

Sight Sciences, Inc. today announced Clinical Ophthalmology has published data from a subgroup analysis of the OLYMPIA trial.